BEAM
Price
$25.05
Change
-$0.07 (-0.28%)
Updated
Sep 27 closing price
37 days until earnings call
VCEL
Price
$43.19
Change
-$0.88 (-2.00%)
Updated
Sep 27 closing price
38 days until earnings call
Ad is loading...

BEAM vs VCEL

Header iconBEAM vs VCEL Comparison
Open Charts BEAM vs VCELBanner chart's image
Beam Therapeutics
Price$25.05
Change-$0.07 (-0.28%)
Volume$654.14K
CapitalizationN/A
Vericel
Price$43.19
Change-$0.88 (-2.00%)
Volume$334.79K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs VCEL Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BEAM vs. VCEL commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and VCEL is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (BEAM: $24.40 vs. VCEL: $49.04)
Brand notoriety: BEAM and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 64% vs. VCEL: 137%
Market capitalization -- BEAM: $2.06B vs. VCEL: $2.12B
BEAM [@Biotechnology] is valued at $2.06B. VCEL’s [@Biotechnology] market capitalization is $2.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, VCEL is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while VCEL’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 6 bearish.
  • VCEL’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -7.19% price change this week, while VCEL (@Biotechnology) price change was -8.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 04, 2024.

VCEL is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($2.12B) and BEAM($2.07B) have the same market capitalization . VCEL YTD gains are higher at: 37.714 vs. BEAM (-10.360).
BEAMVCELBEAM / VCEL
Capitalization2.07B2.12B97%
EBITDAN/AN/A-
Gain YTD-10.36037.714-27%
P/E RatioN/A4319.00-
RevenueN/AN/A-
Total CashN/A17.5M-
Total DebtN/A92.2M-
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVCEL
RSI
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Advances
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
Declines
ODDS (%)
Bearish Trend about 2 months ago
85%
Bearish Trend about 2 months ago
74%
BollingerBands
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-8.55%
NTLA - BEAM
74%
Closely correlated
-3.65%
CRSP - BEAM
72%
Closely correlated
-4.61%
EDIT - BEAM
67%
Closely correlated
-6.68%
DNLI - BEAM
66%
Closely correlated
+2.78%
PRME - BEAM
63%
Loosely correlated
-9.81%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with MDXG. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then MDXG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
-5.05%
MDXG - VCEL
49%
Loosely correlated
-6.73%
FOLD - VCEL
48%
Loosely correlated
+0.17%
NTLA - VCEL
44%
Loosely correlated
-3.65%
CPRX - VCEL
43%
Loosely correlated
-2.52%
BEAM - VCEL
43%
Loosely correlated
-8.55%
More